DCM
IRWD icon

Delpha Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Delpha Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-113
Closed -$1K – 654
2017
Q4 		$1K Buy
+113
New +$1.48K ﹤0.01% 1578

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Delpha Capital Management's IRWD Position: Q1 2018 in Review

Delpha Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2018, closing a stake of 113 shares — an estimated $1K sold.

Delpha Capital Management first reported a position in IRWD in Q4 2017 and held it in 1 quarter. The position peaked at $1K in Q4 2017. 149 funds tracked by Wall St. Rank hold IRWD as of Q1 2018.

  • Delpha Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 113 Ironwood Pharmaceuticals shares in Q1 2018, an estimated $1K.
  • Delpha Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Ironwood Pharmaceuticals position peaked at $1K in Q4 2017.
  • 149 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.